John Conly

Dr. John Conly, MD, CM, CCFP, FRCPC, FCAHS, FAMMI, FACP, FSHEA, FIDSA, is a specialist in infectious diseases in Alberta, Canada.

Conly is an Infectious Disease / IPC Expert for the COVID-19 Scientific Advisory Group under Alberta Health Services.¹⁾

Conly is a Work Package Lead, Principal Investigator, and Executive Committee member of the Antimicrobial Resistance (AMR) One Health Consortium.

Conly served as Chairman of the Board for the Canadian Committee on Antibiotic Resistance (CCAR).

Conly is a member of the Canadian Expert Advisory Group on Antimicrobial Resistance (CEAGAR).

Conly served as Vice Chair of the Canadian Expert Drug Advisory Committee (CEDAC).

Conly formerly served as President of the Canadian Infectious Disease Society (CIDS).

Conly is a Professor of Medicine, Microbiology, Immunology & Infectious Diseases, Pathology & Laboratory Medicine in the Department of Medicine (Infectious Diseases), Cumming School of Medicine, University of Calgary, where he is also the former Head of the Department of Medicine.²⁾

Conly is the Co-Director for the Snyder Institute for Chronic Diseases at the University of Calgary.

Conly is the Medical Director of W21C.³⁾

Conly is a member of the World Health Organization Advisory Group on Integrated Surveillance of Antimicrobial Resistance.